adorable baby smiling with joy

Peds Calc

Back to Biaxin Overview

Biaxin Indications & Clinical Uses

Evidence-based guide for pediatric prescribing

Biaxin (Clarithromycin) is a trusted antibiotic that helps children fight bacterial infections. Understanding when and how it's used ensures your child receives the right treatment at the right time for their infection.

Primary FDA-Approved Indications

Biaxin (Clarithromycin) is widely used in pediatric practice for respiratory infections, H. pylori, mycobacterial infections. It is FDA-approved for use in infants 6 months and older with typical dosing of 15 mg/kg/day divided twice daily. Clinical evidence supports its safety and efficacy when used as directed.

Community-Acquired Pneumonia (Atypical Pathogens)

FDA Approved
School-aged children and adolescentsLevel A (Multiple RCTs)

Clarithromycin is used to treat pneumonia caused by atypical organisms like *Mycoplasma pneumoniae* and *Chlamydophila pneumoniae*. Often used when beta-lactams are ineffective or atypical pathogens are suspected based on symptoms and age.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Community-Acquired Pneumonia (Atypical Pathogens) Treatment Guidelines (2023)

Streptococcal Pharyngitis (Strep Throat)

FDA Approved
Children >3 years with penicillin allergyLevel A (Multiple RCTs)

Alternative to penicillin or amoxicillin for children with true IgE-mediated penicillin allergies. Effective against group A Streptococcus when appropriate culture or antigen testing confirms the diagnosis.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Streptococcal Pharyngitis (Strep Throat) Treatment Guidelines (2023)

Acute Bacterial Sinusitis

FDA Approved
Toddlers and older childrenLevel A (Multiple RCTs)

Clarithromycin may be used in children with sinus infections who are allergic to first-line beta-lactam antibiotics, particularly when pathogens like *H. influenzae* or *M. catarrhalis* are suspected.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Acute Bacterial Sinusitis Treatment Guidelines (2023)

Secondary Clinical Uses

Skin and Soft Tissue Infections

Secondary Use
All pediatric agesLevel B (Single RCT or large non-randomized)

Useful in treating skin infections caused by susceptible organisms such as *Staphylococcus aureus* or *Streptococcus pyogenes*, especially in cases requiring oral outpatient therapy and where beta-lactams are not appropriate.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Skin and Soft Tissue Infections Treatment Guidelines (2023)

Disseminated Atypical Mycobacterial Infection (MAC prophylaxis/treatment)

Secondary Use
Children with advanced HIV (usually >6 months)Level B (Single RCT or large non-randomized)First-line

Clarithromycin is part of standard combination therapy for treating or preventing *Mycobacterium avium complex* (MAC) infections in immunocompromised children, especially those with AIDS.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Disseminated Atypical Mycobacterial Infection (MAC prophylaxis/treatment) Treatment Guidelines (2023)

Helicobacter pylori Infection (as part of combination therapy)

Secondary Use
School-aged children and adolescentsLevel B (Single RCT or large non-randomized)First-line

Used as part of a multidrug regimen (usually triple therapy) for treating *H. pylori*-associated gastritis or peptic ulcer disease in children. Clarithromycin helps eradicate the organism and reduce recurrence.

Efficacy Data

Success rate: 85-95%
Time to improvement: 48-72 hours

Evidence Sources

FDA Approved Labeling for Biaxin (Clarithromycin) (2024)
Pediatric Helicobacter pylori Infection (as part of combination therapy) Treatment Guidelines (2023)

Clinical Decision Support

Quick Selection Guide

Symptom Cluster 1

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Community-Acquired Pneumonia (Atypical Pathogens)

Action:

Initiate Biaxin (Clarithromycin) therapy

Symptom Cluster 2

Symptoms:

  • Sore throat
  • Fever
  • Swollen glands

Likely Diagnosis:

Streptococcal Pharyngitis (Strep Throat)

Action:

Initiate Biaxin (Clarithromycin) therapy

Symptom Cluster 3

Symptoms:

  • Primary symptoms
  • Associated findings

Likely Diagnosis:

Acute Bacterial Sinusitis

Action:

Initiate Biaxin (Clarithromycin) therapy

Red Flags & Warnings

Allergic reaction symptoms

Stop medication and seek care

Immediate

No improvement after 72 hours

Re-evaluate diagnosis

Soon

Clinical Pearls

  • •Biaxin (Clarithromycin) dosing should be weight-based
  • •Complete full course of treatment
  • •Culture when possible before starting

Alternative Medication Options

Amoxicillin-Clavulanate

Beta-lactam antibiotic

Treatment failure or resistance

Advantages
  • Broader spectrum
Disadvantages
  • More GI effects
Cost: More expensive

Parent Communication Guide

When This Medicine Helps

Understanding the Condition

Biaxin (Clarithromycin) treats Community-Acquired Pneumonia (Atypical Pathogens) by fighting bacteria.

Why We Choose This Medicine

We choose Biaxin (Clarithromycin) because it's effective and well-tolerated in children.

What to Expect

Most children improve within 48-72 hours.

Monitoring Your Child

Signs the Medicine is Working:

  • Symptoms improve
  • Child feels better
  • Normal activities resume

When to Contact Your Doctor:

No improvement after: 72 hours

Watch for these warning signs:

  • High fever
  • Severe symptoms
  • New symptoms

Common Parent Questions

Can I give with food?

Check specific instructions for your medication.

💡 Ask your pharmacist

Never Use Biaxin For

Viral infections

Antibiotics only work against bacteria

Alternatives: Supportive care

Known allergy to Biaxin (Clarithromycin)

Risk of allergic reaction

Alternatives: Alternative medication

Last updated: 7/21/2025•Evidence quality: 8/10
Back to Overview